Adding Unicycive (UNCY) $0.75 to the Watch List.

Similar to Ardlyx (ARDX) which we added to the Watch List last week, Unicycive (no we don't know how they pronounce it) which will call UNCY - is...

With Help of Sanofi (SNY), Dario Health (DRIO) Builds Scientific Case for Its Diabetes...

We always find it Interesting when a Company with a $130 billion market cap (Sanofi: SNY), teams up with a Company...

Provention (PRVB) Price Target $18.

Headline Says Downgrade, But That's Near 300% Higher From Here! LIVE QUOTE

Ranked: The Most Popular Drugs in the U.S.

Sorting the annual prescribed medicines data by the total number of patients highlights how important and prevalent some drugs are in America.

We’re Bearish, but we’re up 243% in Provention Bio (PRVB) Today.

And up 416%, from Adding it to 2022 Watch List! Great way to wake up after a night of...

Lantern Pharma (LTRN) $21.25 and Provention Bio (PRVB) $13.51 Added to Biotech Six Pack.

The 2021 Biotech Six Pack: Stocks We Expect to Double! These are ideas #3 and #4 for the 'Biotech...

Adding ENDRA Life Sciences (NDRA) $0.89 to Watch List.

Another Fatty Liver Idea. This Time a Play on Detecting Fatty Liver Non-Invasively. Heads Up. Nearing Resistance at $0.89.

He Shoots And He Scores. Ardelyx (ARDX) Gains 78%. Happy New Year!

Ah yes, and Gains Come to the Patient, as the FDA Moves the Ardelyx Ball Further Along.
Internet Stock Review, Biotech Stock Review, Roland Rick Perry

Unicycive Therapeutics (UNCY) $2.73 Tacks on Another 30%. We’re now up 249%.

Quick way to Jinx Things... Stormin..Live Quote We're still not...

Adding Dario Health (DRIO) $2.81 to Watch List.

LIVE QUOTE Adding DarioHealth to Top Stocks of 2023...

Latest article

Post Reverse Split, Tharimmune (THAR) Announces Positive Phase I Results.

This is a story of 're-purposed' FDA approved drug, from drug overdose, to a solution for unrelenting itching. If approved, it can...

Trump’s (DJT) up 48% Today

LIVE QUOTE Our only thought is it would be a great idea, to give...

Altamira Thera (CYTO) Explodes 144% Higher Post Reverse Split, With 50 Million Shares Trading...

Taking advantage of post reverse-split investor pessimism, is a VALID investing technique. Altamira is developing and supplying peptide-based...